270 related articles for article (PubMed ID: 16024064)
1. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
Cocco L; Manzoli L; Palka G; Martelli AM
Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
[TBL] [Abstract][Full Text] [Related]
2. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia.
Lo Vasco VR; Calabrese G; Manzoli L; Palka G; Spadano A; Morizio E; Guanciali-Franchi P; Fantasia D; Cocco L
Leukemia; 2004 Jun; 18(6):1122-6. PubMed ID: 15085153
[TBL] [Abstract][Full Text] [Related]
3. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L
Int J Mol Med; 2006 Aug; 18(2):267-71. PubMed ID: 16820933
[TBL] [Abstract][Full Text] [Related]
4. Nuclear phospholipase C: involvement in signal transduction.
Manzoli L; Martelli AM; Billi AM; Faenza I; Fiume R; Cocco L
Prog Lipid Res; 2005 Jul; 44(4):185-206. PubMed ID: 15896848
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus.
Fiume R; Teti G; Faenza I; Cocco L
Methods Mol Biol; 2010; 645():143-64. PubMed ID: 20645187
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
[TBL] [Abstract][Full Text] [Related]
7. Nuclear inositide signaling in myelodysplastic syndromes.
Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
[TBL] [Abstract][Full Text] [Related]
8. Physiology and pathology of nuclear phospholipase C β1.
Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
[TBL] [Abstract][Full Text] [Related]
9. Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis.
Manzoli L; Billi AM; Rubbini S; Bavelloni A; Faenza I; Gilmour RS; Rhee SG; Cocco L
Cancer Res; 1997 Jun; 57(11):2137-9. PubMed ID: 9187110
[TBL] [Abstract][Full Text] [Related]
10. Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.
Mongiorgi S; Follo MY; Clissa C; Giardino R; Fini M; Manzoli L; Ramazzotti G; Fiume R; Finelli C; Cocco L
Curr Top Microbiol Immunol; 2012; 362():235-45. PubMed ID: 23086421
[TBL] [Abstract][Full Text] [Related]
11. [Expression of cell cycle control genes in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
[TBL] [Abstract][Full Text] [Related]
12. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
14. Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction.
Martelli AM; Fiume R; Faenza I; Tabellini G; Evangelista C; Bortul R; Follo MY; Falà F; Cocco L
Histol Histopathol; 2005 Oct; 20(4):1251-60. PubMed ID: 16136505
[TBL] [Abstract][Full Text] [Related]
15. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.
Matteucci A; Faenza I; Gilmour RS; Manzoli L; Billi AM; Peruzzi D; Bavelloni A; Rhee SG; Cocco L
Cancer Res; 1998 Nov; 58(22):5057-60. PubMed ID: 9823310
[TBL] [Abstract][Full Text] [Related]
16. Nuclear inositol lipid cycle: a new central intermediary in signal transduction.
Manzoli L; Gilmour RS; Martelli AM; Billi AM; Cocco L
Anticancer Res; 1996; 16(6A):3283-6. PubMed ID: 9042301
[TBL] [Abstract][Full Text] [Related]
17. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
[TBL] [Abstract][Full Text] [Related]
18. Nuclear phospholipase C: a novel aspect of phosphoinositide signalling.
Manzoli L; Billi AM; Faenza I; Matteucci A; Martelli AM; Peruzzi D; Falconi M; Rhee SG; Gilmour RS; Cocco L
Anticancer Res; 1999; 19(5A):3753-6. PubMed ID: 10625953
[TBL] [Abstract][Full Text] [Related]
19. Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors.
Bertagnolo V; Marchisio M; Pierpaoli S; Colamussi ML; Brugnoli F; Visani G; Zauli G; Capitani S
J Leukoc Biol; 2002 Jun; 71(6):957-65. PubMed ID: 12050180
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
